AnazaoHealth Corporation
FDA 503B outsourcing facility
Las Vegas, Nevada
Key Takeaways
- FDA-registered 503B outsourcing facility since 2014
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: August 8, 2025
- 3 FDA drug recalls on record (2015 to 2023)
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- September 23, 2014
- Most recent registration
- December 30, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- August 8, 2025
The FDA last inspected AnazaoHealth Corporation on August 8, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
FDA recall history
AnazaoHealth Corporation has 3 FDA drug recalls on record between 2015 and 2023, based on the FDA enforcement database. Breakdown: 3 Class II.
Recall reasons on record include presence of particulate matter; good manufacturing practices deviations: the product has an active pharmaceutical.
| Date | Class | Product | Reason |
|---|---|---|---|
| November 2023 | Class II | Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection Solution, 30mL Amber Glass Vial, Rx only, AnazaoHealth, 7465 W. Sunset Road, Las Ve | Presence of Particulate Matter. |
| November 2023 | Class II | B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose | Presence of Particulate Matter. |
| January 2015 | Class II | Compounded Plaquex, intravenous injection, 50 ML vial. Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alc | Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source. |
FDA recall classes signal severity, not intent: Class I means a reasonable probability of serious harm, Class II a temporary or reversible risk, Class III a violation unlikely to cause harm. Sterile compounders routinely recall lots as a precaution. FDA definitions.
What this facility compounds
AnazaoHealth Corporation reports compounding 18 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
Tracked on PeptideGrids: Glutathione, Tirzepatide.
- Anastrozole; Testosterone
- Arginine Hydrochloride; Proline; Glutamine; Lysine Hydrochloride
- Ascorbic Acid
- Choline Chloride; Methionine; Inositol; Cyanocobalamin
- Estradiol
- Glutathione
- Lysine Hydrochloride
- Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine
- Methionine; Inositol; Choline Chloride
- Methylcobalamin
- Nandrolone Decanoate
- Nicotinamide-Adenine Dinucleotide Phosphate, Reduced
- Pyridoxine Hydrochloride; Magnesium Chloride; Dexpanthenol; Calcium Gluconate; Thiamine Hydrochloride; Niacinamide; Cyanocobalamin; Riboflavin
- Pyridoxine Hydrochloride; Thiamine Hydrochloride
- Testosterone
- Testosterone Cypionate
- Thioctic Acid, (-)
- Tirzepatide
Location
7465 W Sunset Rd Ste 1200, Las Vegas, NV 89113-1944
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Vic Williams, 800-995-4363. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of AnazaoHealth Corporation with the Nevada State Board of Pharmacy.
503B facilities in Nevada
Nevada has 2 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Nevada.
Frequently asked questions
Is AnazaoHealth Corporation registered with the FDA?
Yes. AnazaoHealth Corporation is a registered 503B outsourcing facility, first registered with the FDA on September 23, 2014 and most recently registered on December 30, 2025.
Has AnazaoHealth Corporation been inspected by the FDA?
The FDA last inspected AnazaoHealth Corporation on August 8, 2025. A Form FDA 483 was issued.
Has AnazaoHealth Corporation had any FDA drug recalls?
AnazaoHealth Corporation has 3 FDA drug recalls on record (2015 to 2023) in the FDA enforcement database.
What does AnazaoHealth Corporation compound?
AnazaoHealth Corporation reports compounding 18 active ingredients to the FDA, including Glutathione, Tirzepatide.
Where is AnazaoHealth Corporation located?
AnazaoHealth Corporation is located in Las Vegas, Nevada (7465 W Sunset Rd Ste 1200).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026. Recall history from the FDA openFDA drug enforcement database, retrieved June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by AnazaoHealth Corporation. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.